PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.85%
Negative revenue growth while UPM.HE stands at 1.02%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-16.31%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-89.49%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-89.49%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-76.26%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-76.43%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-76.43%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.28%
Share change of 0.28% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.28%
Diluted share change of 0.28% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
391.03%
OCF growth above 1.5x UPM.HE's 39.65%. David Dodd would confirm a clear edge in underlying cash generation.
191.44%
FCF growth above 1.5x UPM.HE's 109.15%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-3.24%
Negative 10Y revenue/share CAGR while UPM.HE stands at 3.53%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
2.12%
Positive 5Y CAGR while UPM.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
3.58%
3Y revenue/share CAGR under 50% of UPM.HE's 27.42%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
793.33%
10Y OCF/share CAGR above 1.5x UPM.HE's 121.98%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
43.94%
5Y OCF/share CAGR is similar to UPM.HE's 48.04%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
4.91%
3Y OCF/share CAGR under 50% of UPM.HE's 75.62%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-33.77%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-91.72%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-89.81%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
129.33%
10Y equity/share CAGR above 1.5x UPM.HE's 52.85%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.29%
5Y equity/share CAGR above 1.5x UPM.HE's 24.47%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
44.74%
3Y equity/share CAGR above 1.5x UPM.HE's 22.15%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.53%
Firm’s AR is declining while UPM.HE shows 0.05%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-13.82%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.77%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.31%
We have a declining book value while UPM.HE shows 0.98%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-2.03%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-6.32%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.